The Bangalore-based Molecular Connections, a new-biology research and drug discovery services company, is gearing up to launch its insilico drug target validation tool this month.
The company will be collaborating with a US-based pharma major for launching this product. The market size for the tool is estimated at $2.5 billion.
Molecular Connections is a joint venture between Idea2solutions Private Ltd, an incubator promoted by the founders of the Dr Reddy
